CITIUS PHARMACEUTICALS, INC. (CTXR) Net income 2016–2025
CITIUS PHARMACEUTICALS, INC. (CTXR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$39.7MFY2025 · since FY2016: -$8.3M → -$39.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.7M | -0.8% |
| FY2024 | -$39.4M | -21.2% |
| FY2023 | -$32.5M | +3.3% |
| FY2022 | -$33.6M | -45.9% |
| FY2021 | -$23.1M | -31.4% |
| FY2020 | -$17.5M | -12.8% |
| FY2019 | -$15.6M | -24.1% |
| FY2018 | -$12.5M | -20.7% |
| FY2017 | -$10.4M | -25.2% |
| FY2016 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice